AFT Pharmaceuticals Limited

NZSE:AFT Stok Raporu

Piyasa değeri: NZ$281.0m

AFT Pharmaceuticals Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 5/6

AFT Pharmaceuticals yıllık ortalama 20.3% oranında kazançlarını artırırken, Pharmaceuticals sektöründe kazançlar growing at 35.4% annual. Gelirler growing yılda ortalama 15.5% oranında artmaktadır. AFT Pharmaceuticals'in özkaynak karlılığı 17.8% ve net marjı 8%'dir.

Anahtar bilgiler

20.3%

Kazanç büyüme oranı

20.7%

EPS büyüme oranı

Pharmaceuticals Sektör Büyümesi35.6%
Gelir büyüme oranı15.5%
Özkaynak getirisi17.8%
Net Marj8.0%
Sonraki Kazanç Güncellemesi20 Nov 2024

Yakın geçmiş performans güncellemeleri

Recent updates

It's Unlikely That The CEO Of AFT Pharmaceuticals Limited (NZSE:AFT) Will See A Huge Pay Rise This Year

Jul 26
It's Unlikely That The CEO Of AFT Pharmaceuticals Limited (NZSE:AFT) Will See A Huge Pay Rise This Year

AFT Pharmaceuticals Limited (NZSE:AFT) Just Released Its Yearly Results And Analysts Are Updating Their Estimates

May 25
AFT Pharmaceuticals Limited (NZSE:AFT) Just Released Its Yearly Results And Analysts Are Updating Their Estimates

Does AFT Pharmaceuticals (NZSE:AFT) Deserve A Spot On Your Watchlist?

May 22
Does AFT Pharmaceuticals (NZSE:AFT) Deserve A Spot On Your Watchlist?

Is Now The Time To Put AFT Pharmaceuticals (NZSE:AFT) On Your Watchlist?

Oct 17
Is Now The Time To Put AFT Pharmaceuticals (NZSE:AFT) On Your Watchlist?

Should You Be Adding AFT Pharmaceuticals (NZSE:AFT) To Your Watchlist Today?

May 23
Should You Be Adding AFT Pharmaceuticals (NZSE:AFT) To Your Watchlist Today?

Is AFT Pharmaceuticals Limited (NZSE:AFT) Trading At A 50% Discount?

Dec 01
Is AFT Pharmaceuticals Limited (NZSE:AFT) Trading At A 50% Discount?

We Discuss Whether AFT Pharmaceuticals Limited's (NZSE:AFT) CEO Is Due For A Pay Rise

Jul 30
We Discuss Whether AFT Pharmaceuticals Limited's (NZSE:AFT) CEO Is Due For A Pay Rise

With AFT Pharmaceuticals Limited (NZSE:AFT) It Looks Like You'll Get What You Pay For

Jun 02
With AFT Pharmaceuticals Limited (NZSE:AFT) It Looks Like You'll Get What You Pay For

Should You Be Impressed By AFT Pharmaceuticals Limited's (NZSE:AFT) ROE?

Mar 20
Should You Be Impressed By AFT Pharmaceuticals Limited's (NZSE:AFT) ROE?

A Quick Analysis On AFT Pharmaceuticals' (NZSE:AFT) CEO Compensation

Feb 13
A Quick Analysis On AFT Pharmaceuticals' (NZSE:AFT) CEO Compensation

Are AFT Pharmaceuticals's (NZSE:AFT) Statutory Earnings A Good Reflection Of Its Earnings Potential?

Jan 23
Are AFT Pharmaceuticals's (NZSE:AFT) Statutory Earnings A Good Reflection Of Its Earnings Potential?

Does AFT Pharmaceuticals (NZSE:AFT) Have A Healthy Balance Sheet?

Jan 02
Does AFT Pharmaceuticals (NZSE:AFT) Have A Healthy Balance Sheet?

Should AFT Pharmaceuticals (NZSE:AFT) Be Disappointed With Their 89% Profit?

Dec 12
Should AFT Pharmaceuticals (NZSE:AFT) Be Disappointed With Their 89% Profit?

AFT Pharmaceuticals Limited Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Nov 21
AFT Pharmaceuticals Limited Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Gelir ve Gider Dağılımı

AFT Pharmaceuticals nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.


Kazanç ve Gelir Geçmişi

NZSE:AFT Gelir, gider ve kazançlar (NZD Millions )
TarihGelirKazançlarG+A GiderleriAr-Ge Giderleri
31 Mar 2419516586
31 Dec 2318513576
30 Sep 2317511565
30 Jun 2316611534
31 Mar 2315711494
31 Dec 2214914464
30 Sep 2214117424
30 Jun 2213518404
31 Mar 2213020384
31 Dec 2112515383
30 Sep 2112011393
30 Jun 211169382
31 Mar 211138372
31 Dec 201105361
30 Sep 201073360
30 Jun 201077370
31 Mar 2010612370
31 Dec 1910011360
30 Sep 199411351
30 Jun 19894351
31 Mar 1985-3351
31 Dec 1884-7382
30 Sep 1883-11404
30 Jun 1882-12395
31 Mar 1881-14397
31 Dec 1779-14378
30 Sep 1776-143410
30 Jun 1773-163410
31 Mar 1769-18349
31 Dec 1667-18338
30 Sep 1664-18328
30 Jun 1664-16307
31 Mar 1664-13296
31 Dec 1563-13275
30 Sep 1562-13264
30 Jun 1559-13254
31 Mar 1556-13245
31 Mar 1449-1162

Kaliteli Kazançlar: AFT yüksek kaliteli kazançlar sağlıyor.

Büyüyen Kar Marjı: AFT 'nin mevcut net kar marjları (8%) geçen yılın (6.8%) sinden daha yüksektir.


Serbest Nakit Akışı ve Kazanç Analizi


Geçmiş Kazanç Büyüme Analizi

Kazanç Eğilimi: AFT son 5 yılda karlı hale geldi ve kazançlarını yıllık 20.3% oranında artırdı.

Büyüme Hızlandırma: AFT 'un son bir yıldaki kazanç büyümesi ( 46.5% ) 5 yıllık ortalamasını (yıllık 20.3% ) aşıyor.

Kazançlar vs. Sektör: AFT geçen yılki kazanç büyümesi ( 46.5% ) Pharmaceuticals sektörünün 46.5% değerini aştı.


Özkaynak Getirisi

Yüksek ROE: AFT 'nin Özsermaye Getirisi ( 17.8% ) düşük olarak değerlendiriliyor.


Varlık Getirisi


Kullanılan Sermaye Getirisi


Geçmişte güçlü performans gösteren şirketleri keşfedin